AIDS Treatment NewsImportant note: Information in this article was accurate in 2004. The state of the art may have changed since the publication date.
Click here to return to AIDS Treatment News main menu
Print this Article

DonateNow



Warning on Two Specific 3-Drug Regimens: Viread + Videx + Either Sustiva or Viramune

AIDS TREATMENT NEWS - November 23, 2004
John S. James


Summary: Two more three-drug antiretroviral regimens have unexpectedly failed to control HIV in many patients. But some related regimens do seem to be working well.


On November 12 the U.S. Food and Drug Administration's AIDS listserve noted a Dear Doctor letter from Bristol-Myers Squibb, warning that the two particular three-drug combinations noted above had shown a high rate of virologic failure in treatment-naive patients with high viral loads (about half of those patients failed the treatment). The problem seems to be specific to these regimens, as Sustiva has worked with Viread-based regimens, and with Videx-based regimens, in different trials.

The FDA email is available on its archive, http://www.fda.gov/oashi/aids/listserve/listserve2004.html (you need to scroll down or use a search in your browser). And this page has the full BMS Dear Doctor letter attached.

Comment

There are now several antiretroviral regimens that failed to control the virus, and were not predicted to fail on the basis of clinical trials, physicians' experience, and known drug interactions. The leading theory seems to be that the bad combinations have a genetic barrier against the virus that is too low. If so, then it may be possible to better predict such failures from existing resistance data -- and perhaps to improve other regimens as well, by avoiding possible weaknesses that are less serious but still important. Has anybody yet brought this information together into a model that works?

041123
ATN041102


Copyright © 2004 - by John S. James. See "Permission to Copy" at: http://www.aidsnews.org/canhelp. How to help AIDS Treatment News: http://www.aidsnews.org/canhelp.

AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2004. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2004. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .